Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PF 06760805

Next Previous
Search
Drug Profile

PF 06760805

Alternative Names: GBS infection vaccine - Pfizer; GBS6; GBS6 - Pfizer; Group B streptoccous 6-valent polysaccharide conjugate vaccine - Pfizer; Hexavalent Group B streptococcus vaccine - Pfizer; Multivalent group B streptococcus vaccine - Pfizer; PF-06760805

Latest Information Update: 29 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Class Streptococcal vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Streptococcal infections

Most Recent Events

  • 04 Mar 2024 Pfizer completes the phase I/II in Streptococcal infections (adolescent, adult, child, infant, neonate, prevention) in South Africa, UK and USA (IM) (NCT03765073)
  • 19 Jul 2023 Adverse events data from a phase II trial in Streptococcal infections released by Pfizer
  • 19 Jul 2023 Pfizer plans a phase III trial for Streptococcal infections

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top